Daohong Zhou

Biography

Mr. Daohong Zhou, M.D. founded Unity Biotechnology, Inc. in 2011. Mr. Zhou's research focuses on radiation and chemotherapy induced hematopoietic stem cell injury and leukemia and on development of mechanism-based strategies to protect the hematopoietic system from cancer therapy-induced damage and novel medical countermeasures against radiological/nuclear accidents or terrorism. He has published more than 50 peer reviewed scientific articles and book chapters. His research is well funded by grants from the National Cancer Institute (NCI) and National Institute of Allergy and Infectious Disease (NIAID). He serves on several national and international peer review panels. He is a regular member of the Radiation Therapeutics and Biology Study Section, the panel that reviews radiation-related projects submitted to the National Institutes of Health (NIH). He has been named as the Winthrop P. Rockefeller Endowed Chair for Leukemia Research at the Winthrop P. Rockefeller Cancer Institute. He also serves as an Honorary Professor of the Peking Union Medical College in China.

Research Interest

Blood Disorder,stem cell